Barbara Porsche

Dr. Barbara Porsche

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ADAnastasia Dressler
Anastasia Dressler
LBLetizia Bonfanti
Letizia Bonfanti
PTPetra Trimmel-Schwahofer
Petra Trimmel-Schwahofer
BPBarbara Porsche
Barbara Porsche
SBSimona Bertoli
Simona Bertoli
CMChristoph Male
Christoph Male
Objectives: The aim of this study was to evaluate the effectiveness of sequential treatments with adrenocorticotropic hormone (ACTH) or ketogenic diet therapy (KDT) in infants with infantile epileptic spasms syndrome (IESS) who did not achieve seizure freedom after initial treatment with either KDT or ACTH. Methods: We conducted a cohort study following a parallel-cohort randomized controlled trial comparing KDT with ACTH as first-line treatment for IESS. Infants who failed to respond were switched per protocol to the alternative treatment (ACTH or KDT) or, if this was not feasible or unsuccessful, to anti-seizure medications (ASMs). The primary outcome was the frequency of sustained seizure freedom at last follow-up. Results: Of 101 infants allocated to the initial treatment phase, N = 67 required further treatment. Of these, 31% (21/67) achieved sustained seizure freedom after the second treatment phase, and 15% (7/46) after rescue treatment with ASMs. KDT as the second treatment achieved sustained seizure freedom in 50% (12/24), compared to 19% (3/16) with ACTH and 9% (2/22) with ASMs. The cumulative response rate after the first and second treatments was 64% for the KDT-ACTH sequence and 68% for the ACTH-KDT sequence. The cumulative response after all three treatment phases was 78% (KDT-ACTH-ASM) and 72% (ACTH-KDT-ASM), respectively. Conclusions: KDT is at least as effective as ACTH as a second treatment and significantly more effective than ASMs in achieving sustained seizure freedom in infants with IESS.

1 February 2008 in Neuropediatrics
Verified
Journal Article
Closed access
GGGudrun Gröppel
Gudrun Gröppel
ADAnastasia Dressler
Anastasia Dressler
MFM. Freilinger
M. Freilinger
EGEllen Gelpi
Ellen Gelpi
HMH. Mayer
H. Mayer
MFM. Feucht
M. Feucht
Purpose: To identify the postoperative course, the neuropsychological development and the prognostic value of presurgical collected data in a group of patients after hemispherotomy or partial disconnection because of epilepsy and epileptic encephalopathy. Patients and Methods: We analyzed a group of 15 children. The postoperative follow up period was at least 3 months. We examined the postoperative neuropsychological development and changes in the pathological EEG as well as following parameters: (1) age at onset, (2) duration of epilepsy, (3) side of surgery, (4) preoperative seizure frequency, (5) history of epilepsy in the family, (6) trauma, (7) meningitis/encephalitis, (8) complication during pregnancy and birth, (9) febrile convulsions, (10) type of seizures, (11) preoperative deficit in the neurological examination and (12) results of the histological examination. The outcome was measured with the classification scheme of Wieser et al. Results: Three months after surgery 13 children were seizure free. One child showed postoperative complications. Four patients showed a new postoperative hemianopsia additionally, but no patient had a new postoperative hemiparesis. We showed a significant improvement in the neuropsychological development and the EEG results. Conclusions: We showed an excellent outcome after hemispherotomy and partial disconnection in our group of patients. Our patients had an improvement in their neuropsychological development and a decrease of pathological EEG results. Our results demonstrate that children with epileptic encephalopathy benefit from hemispherotomy and have a small postoperative risk of complications.

18 June 2019 in Epilepsia
Verified
Journal Article
Closed access
PDF file
MFMartha Feucht
Martha Feucht
ADAnastasia Dressler
Anastasia Dressler
FBFranz Benninger
Franz Benninger
PTPetra Trimmel‐Schwahofer
Petra Trimmel‐Schwahofer
GGGudrun Gröppel
Gudrun Gröppel
CMChristoph Male
Christoph Male

11 September 2019 in Neuropediatrics
Verified
Conference Paper
Closed access
ADAnastasia Dressler
Anastasia Dressler
CHChiara Häfele
Chiara Häfele
PTPetra Trimmel-Schwahofer
Petra Trimmel-Schwahofer
FBFranz Benninger
Franz Benninger
BPBarbara Porsche
Barbara Porsche
CMChristoph Male
Christoph Male
Aim: To assess in infants with West Syndrome after failure of first treatment with either the ketogenic diet (KD) or standard adrenocorticotropic hormone (ACTH), the effectiveness of successive treatments with ACTH, KD, or antiepileptic drugs (AEDs). Method: This is a per protocol follow-up study of infants with WS after failure to the first treatment with KD or ACTH in a parallel-cohort randomized controlled trial. Infants were switched to the respective other treatment (ACTH or KD), or if impossible to AEDs for second treatment, and if failing to respond, to AEDs as third treatment. Study outcome was the frequency of sustained seizure freedom until last follow-up, assessed in response to second treatment, and cumulative responses after first and second treatment. Results: 101 infants were included into the study. Overall, 34% of infants showed sustained seizure freedom in response to first treatment, 31% to the second and 15% to the third treatment. Cumulative response after third treatment was 61%. KD as second treatment achieved sustained seizure freedom in 50%, ACTH in 19%, and AEDs in 9%. Children eligible for epilepsy surgery as second treatment achieved sustained seizure freedom in 80%. After a third treatment with AEDs, cumulative response after a KD-ACTH sequence was 78%, and 72% after an ACTH-KD sequence. Subgroup analysis with Vigabatrin showed second KD treatment to be more effective than ACTH, but no difference for third treatment with AEDs. Interpretation: The KD is at least as effective as ACTH as second treatment and significantly more effective than AED in achieving sustained seizure freedom.

1 December 2008 in Neuropediatrics
Verified
Journal Article
Closed access
BPBarbara Porsche
Barbara Porsche
MFM. Feucht
M. Feucht
Purpose: To evaluate prospectively pre- and postoperative neuropsychological performance of children with temporal lobe epilepsy (TLE) and low IQ (≤85) compared to those with IQ >85. Methods: IQ, concentration, flexibility in thinking, and verbal/non-verbal memory were assessed before, 3 months and once/year after surgery (a.s.). Group and individual changes as well as outcome-predictors were evaluated. Results: 19 patients with low IQ (6–18 years; 12 right TLE) and 22 age-matched patients with average range intelligence (10 right TLE) were included. 3 months a.s., significantly improved verbal (V-IQ), performance (P-IQ), and full scale IQs (FS-IQ) were identified in low-IQ patients whereas patients with average-range intelligence tend to worsen in their V-IQ. 1 year a.s., improvement of V-IQ, P-IQ and FS-IQ was observed in the whole group. Long-term outcome data (2–6 years a.s.) for 20 children also showed significant improvement in P-IQ and FS-IQ for both groups. Data of individual changes corroborat these findings. Concentration improved for both groups (especially for the low IQ-patients) 3 months a.s. and 1 year a.s. Long term verbal memory outcome showed a significant improvement in both groups, especially for the left TLE. IQ-groups did not differ significantly in age at seizure onset and duration of epilepsy. Conclusion: Due to our results, epilepsy surgery and surgical intervention is advisable in children with low cognitive function.

1 December 2008 in Neuropediatrics
Verified
Journal Article
Closed access
GGGudrun Gröppel
Gudrun Gröppel
ADA. Dressler
A. Dressler
MFM. Freilinger
M. Freilinger
HMH. Mayer
H. Mayer
GPG. Pahs
G. Pahs
MFM. Feucht
M. Feucht
Purpose: Early-onset symptomatic focal epilepsy often is a drug-resistant, catastrophic disorder with a high frequency of seizures and subsequent developmental decline. Early surgery is an excellent therapeutic option for some of these patients. Methods: We included 24 children (10 girls and 14 boys) less than age of 5 years at the time of presurgical evaluation. The median age at seizure onset was 1.0 year (range: first days of life to 3.5 years), the median age at the time of surgery was 3.5 years (range: 0.5 to 5.0 years). Duration of epilepsy showed a range of 0.5 to 4.0 years (median 1.5 years). All patients had a high preoperative seizure frequency ranging from 4 to 11 seizures/year up to more than 10 seizures per day (median: more than 10 seizures per day). We analysed seizure outcome and postoperative development as well as the prognostic relevance of the presurgical clinical and EEG data, the technique of surgery and histopathology. Results: One year after surgery 77.3% of the patients were seizure-free. After 2 years in the group of 11 patients 90.9% had no seizures, 3 years postoperatively 3 of 4 patients were free of seizures, after 4 to 7 years postoperatively one of 2 patients had no seizures. One patient has been free of seizures 8 years after surgery. The majority of our patients showed a significant progress in their development (most impressing in the group of patients with Infantile Spasms). Discussion: Early surgical intervention in this group of patients can interrupt a catastrophic progress and prevent developmental stagnation or even decline. We strongly recommend an early surgical evaluation of these patients.